Skip to main content
Fig. 11 | Stem Cell Research & Therapy

Fig. 11

From: Stem cell-derived exosomes in the treatment of acute myocardial infarction in preclinical animal models: a meta-analysis of randomized controlled trials

Fig. 11

Subgroup analysis showing the effect of cell type. Compared with the control group, exosome therapy improved LVEF (P = 0.000). The exosome therapy derived from HMSC significantly improved LVEF compared with the controls (P = 0.000). There was no significant difference between the treatment of exosomes derived from AMSC (P = 0.258) or EMSC (P = 0.272) and the control group

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512